All Assets

Recovery Insights Lab · Client Deliverable

Powering Recovery

National survey on opioid addiction, recovery, and access to medication — prepared for Indivior.

Prepared for: IndiviorField dates: August 14–18, 2026Sample: n=1,076Margin of error: ±3.7%

Executive Summary

Four numbers that frame the opportunity.

The American public sees opioid addiction as a top-tier crisis, supports medication-based treatment in principle, but faces steep awareness and access barriers.

41%

pick drug addiction as a top-2 health problem

weighted · second only to mental illness (50%)

53%

of gen pop aware FDA-approved medications exist

Q4A · weighted total

53%

of medication users had coverage delayed or denied

Q29A · among recovery respondents who used medication

81%

say no coverage loss over a paperwork error

Q33 · only 4% disagree

The Public's Mandate

Expanding treatment leads the public's priorities.

% ranking each area in their top 3 of 7 · weighted, effective n=705

60%
Expanding treatment availability
56%
Increasing recovery support services
51%
Reducing insurance barriers
46%
Preventing substance use and addiction
35%
Increasing public understanding of addiction
28%
Supporting treatment for incarcerated individuals
25%
Supporting successful reentry after incarceration

The Crisis

The crisis still registers — Washington doesn't.

People in recovery are far more optimistic (44% better) than the public (19%) — recovery is more visible from inside than outside.

Crisis has gotten worse

Gen Pop
46%
Recovery
39%

Crisis has gotten better

Gen Pop
19%
Recovery
44%

Paying less attention than before

35%Elected officials
27%The media
23%The public

The Awareness Gap

Barely half the public knows medications exist.

Only ~1 in 3 has heard of long-acting injectables. Awareness is the first barrier to overcome.

Aware FDA-approved medications exist

Gen Pop
53%
Recovery
77%

Aware of weekly/monthly injectables (among aware)

Gen Pop
65%
Recovery
84%

Heard of inpatient or residential treatment

Gen Pop
63%
Recovery
60%

Heard of peer-support or recovery programs

Gen Pop
59%
Recovery
62%

Heard of medication taken daily

Gen Pop
48%
Recovery
68%

Heard of long-acting medication administered by a provider

Gen Pop
34%
Recovery
51%

Treatment Effectiveness

People in recovery rate every modality higher.

% very or somewhat effective · on prescribed medication, the gap jumps from 70% to 88%.

Medication prescribed by a doctor

Gen Pop
70%
Recovery
88%

Counseling or therapy

Gen Pop
69%
Recovery
88%

Inpatient or residential rehab

Gen Pop
78%
Recovery
89%

Peer support or 12-step program

Gen Pop
68%
Recovery
85%

Faith-based programs

Gen Pop
50%
Recovery
78%

Quitting without any of the above (abstinence)

Gen Pop
34%
Recovery
68%

Medication Flexibility

Every tested feature is rated valuable by huge majorities.

% very or somewhat valuable · provider-administered dosing, extended availability, and multiple options all clear 77%+ in both audiences.

Having more than one medication option

Gen Pop
79%
Recovery
88%

Choosing a treatment that fits individual circumstances

Gen Pop
89%
Recovery
93%

Receiving medication from a provider vs. managing daily dose

Gen Pop
82%
Recovery
90%

Having regular contact with a healthcare provider

Gen Pop
87%
Recovery
91%

Reducing the need to remember medication every day

Gen Pop
80%
Recovery
88%

Having medication available in the body over an extended period

Gen Pop
76%
Recovery
87%

Medication & Recovery

Medication counts as recovery — in principle.

Big majorities agree a person on prescribed medication is still 'in recovery.' But only ~1 in 3 calls it a legitimate treatment outright.

% agree (strongly + somewhat)

"Still in recovery" while on medication

Gen Pop
77%
Recovery
89%

"In long-term recovery" on medication

Gen Pop
76%
Recovery
86%

Forced choice: which comes closest to your view

Medication is a legitimate treatment for a medical condition

GP 35%Rec 39%

Helpful, but should eventually stop to be fully in recovery

GP 33%Rec 34%

Replaces one dependency with another

GP 15%Rec 22%

Do not know enough to have an opinion

GP 16%Rec 5%

Access Barriers

Insurance, cost, and fear top the perceived barriers.

% calling each a major or moderate barrier · gen pop n=772

77%
Insurance factors (no coverage / delayed or denied)
77%
Costs too much
73%
Fear of losing job or housing
65%
No provider nearby
62%
Didn't know the options existed
62%
Stigma from a family/loved one
61%
Transportation
60%
Too many side effects
58%
Don't believe they are effective
56%
Belief it is swapping one drug for another
56%
Too time intensive
51%
Stigma from a health care provider

The Choice Gap

Only 43% of people in recovery say their provider discussed several options.

Even though 80% were at least somewhat aware options existed. · recovery n=304

43%
Several options were discussed
32%
Just one option was discussed
12%
No options were discussed
10%
Did not discuss treatment with a provider
4%
Do not recall

When Insurers Say No

53% of medication users had coverage delayed or denied.

Of those denied: 47% withdrawal, 40% emergency care, 22% overdose. The public expects worse outcomes than those denied actually experienced.

47%

Withdrawal or worsening symptoms

40%

Emergency or hospital care

22%

Overdose

Expected (gen pop) vs. Experienced (recovery n=94) · directional

ConsequenceExpectedExperienced
Return to opioid use72%27%
Withdrawal or worsening symptoms63%47%
Interruption of medication or treatment54%34%
Overdose51%22%
Emergency or hospital care45%40%
Job or housing disruption31%27%
Legal problems31%39%
No lasting effect10%22%

Coverage & Policy

Coverage continuity is consensus territory.

Weighted, concern about Medicaid changes runs 71% of US adults — 74% among current Medicaid enrollees.

Concerned Medicaid changes disrupt treatment

Gen Pop
71%
Recovery
87%

Shouldn't lose Medicaid over paperwork error

Gen Pop
81%
Recovery
88%

Coverage continuity important

Gen Pop
84%
Recovery
90%

Immediate treatment access after jail/prison

Gen Pop
71%
Recovery
83%

Methodology: National survey of US adults. General population results raked to Census (ACS) benchmarks for age, gender, race/ethnicity, and education; recovery segment scaled to 3% of adults. Weighted effective n=705; margin of error ±3.7 points. Delivered by Recovery Insights Lab.

base44
Edit with Base44